This conference will provide attendees with an overview of emerging trends in oncology, solid organ- and blood/marrow transplantation. Join us as clinical experts provide insight into innovative approaches to the ongoing management and continuing support of patients with complex cancers and organ failures.
Specialists will share their insights into: quality-improvement programs in solid organ transplantation; recent developments in kidney allocation, lung, pancreas and heart transplantation; and current strategies in treating chronic pancreatitis, hepatitis C and intestinal failure.
Conference participants will also gain insight into advances in oncology treatments including: emerging immunotherapies, haploidentical stem cell transplantation and robotic surgery. Furthermore, the physical, psychosocial, and financial impact to patients undergoing cancer treatment will be highlighted, as well as how clinical trials are evolving to better understand cancer and identify even more effective treatments.
Need CE Credits?
This conference is designed for health care professionals who care for patients and/or manage their health care benefits, as well as those who have an interest in oncology, blood/marrow transplantation, and/or solid organ transplantation.
** Refer to the Continuing Education page for a listing of certifications that have been applied for and/or approved for this conference.
|Who should attend?*
The instructional level of the educational activity is intermediate.
Conference educational objectives
After completion of this activity, the participant should be able to:
- Explain how quality measures are selected and monitored in a solid organ transplant program.
- Recognize how meeting quality measures impacts patient outcomes.
- Discuss issues of organ allocation in pancreas and kidney transplantation.
- Recognize when transplant is considered in patients being medically managed for advanced lung disease, congestive heart failure and chronic pancreatitis.
- Summarize current and cutting-edge techniques and treatments being used in the management of patients with intestinal failure and hepatitis C.
- Illustrate how the patient’s own immune system is being used to combat cancer.
- Discuss the physical, emotional, social, financial, and legal impact cancer and cancer treatment can have on a patient, as well as how patients and families can be supported during and after treatment.
- Describe advances in haploidentical stem cell transplantation, robotic surgery, and clinical research design and availability are expanding treatment options and improving outcomes for some oncology patients.
- Examine the benefits of having a multidisciplinary team to manage patients with breast cancer and how the treatment by such a team can improve patient outcomes.